Press the button and be introduced to a new random company!

Introduce me >

Social media

facebook   Follow us on Twitter

Coverage

Vitrolife

Vitrolife

Read in Swedish

Vitrolife AB (publ): Interim report January - September 2019: Continued profitable growth

08:30 / 6 November 2019 Vitrolife Press release

Third quarter:
  • Sales amounted to SEK 378 (284) million, corresponding to an increase of 33 percent in SEK. Sales increased by 27 percent in local currency whereof 15 percent comprised organic growth.

  • Operating income before depreciation and amortisation (EBITDA) amounted to SEK 155 (121) million, corresponding to a margin of 41 (43) percent. Fluctuations in exchange rates positively impacted EBITDA by SEK 9 million.

  • Net income amounted to SEK 107 (75) million, which gave earnings per share of SEK 0.98 (0.69).

January - September:
  • Sales amounted to SEK 1 071 (831) million, corresponding to an increase of 29 percent in SEK. Sales increased by 23 percent in local currency whereof 12 percent comprised organic growth.

  • Operating income before depreciation and amortisation (EBITDA) amounted to SEK 428 (343) million, corresponding to a margin of 40 (41) percent. Fluctuations in exchange rates positively impacted EBITDA by SEK 30 million.

  • Net income amounted to SEK 287 (227) million, which gave earnings per share of SEK 2.64 (2.08).

November 6, 2019
Gothenburg
VITROLIFE AB (publ)
Thomas Axelsson, CEO

_________________________________________________________________________________________________________________

Vitrolife is an international medical device Group. Vitrolife develops, produces and markets medical devices for assisted reproduction.

Vitrolife has approximately 400 employees and the company's products are sold in about 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in Australia, Belgium, China, Denmark, France, Germany, Italy, Japan, United Kingdom and USA. The Vitrolife share is listed on NASDAQ Stockholm.

Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail: info@vitrolife.com.Website: www.vitrolife.com/

Show as PDF

Show original from Cision

Cision

This information was distributed by Cision http://www.cisionwire.se/